CHEBI:90875 - Synjardy

ChEBI IDCHEBI:90875
ChEBI NameSynjardy
Stars
DefinitionA mixture composed of empagliflozin and metformin hydrochloride that is used for treatment of type II diabetes.
Last Modified8 January 2016
SubmitterSteve
Roles Classification
Biological Role:
sodium-glucose transport protein subtype 2 inhibitor  Any inhibitor that interferes with the action of sodium-glucose transport protein subtype 2.
Application:
hypoglycemic agent  A drug which lowers the blood glucose level.
ChEBI Ontology
Outgoing Relation(s)
Synjardy (CHEBI:90875) has part empagliflozin (CHEBI:82720)
Synjardy (CHEBI:90875) has part metformin hydrochloride (CHEBI:6802)
Synjardy (CHEBI:90875) has role hypoglycemic agent (CHEBI:35526)
Synjardy (CHEBI:90875) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273)
Synjardy (CHEBI:90875) is a mixture (CHEBI:60004)
Synonyms  Source
Empagliflozin - metformin mixtKEGG DRUG
metformin hydrochloride mixture with empagliflozinChEBI
empagliflozin/metforminChEBI
metformin hydrochloride and empagliflozinChEBI
Empagliflozin mixture with metformin hydrochlorideChemIDplus
Empagliflozin and metformin hydrochlorideChemIDplus
Brand Name  Source
SynjardyKEGG DRUG
Manual XrefsDatabases
D10752KEGG DRUG
Citations